Erin E Longbrake1, Samantha Lancia2, Nhial Tutlam2, Kathryn Trinkaus3, Robert T Naismith2. 1. Department of Neurology, Washington University in St. Louis, St Louis, MO, United States. Electronic address: longbrakee@neuro.wustl.edu. 2. Department of Neurology, Washington University in St. Louis, St Louis, MO, United States. 3. Division of Biostatistics, Washington University in St. Louis, St Louis, MO, United States.
Abstract
BACKGROUND: Visual dysfunction in MS can be quantified using a variety of tests. Many vision tests have not been formally evaluated among MS patients with existing visual dysfunction. OBJECTIVE: Evaluate several versions of visual acuity and contrast sensitivity tests, measures of central and peripheral vision, retina structure, electrophysiologic function, and quality of life among MS patients with moderate/severe visual dysfunction. METHODS: Cross-sectional study of 46 patients with stable, incompletely recovered optic neuritis. Testing included Snellen eye charts, several Sloan low contrast charts, Pelli Robson (PR) contrast sensitivity charts, optical coherence tomography, visual fields, Farnsworth Munsell 100-hue test, visual evoked potentials (VEP), and visual function quality of life (VFQ-25) testing. RESULTS: 98% of eyes could read two lines of the PR chart, while only 43% read the 2.5% contrast chart. Low contrast tests correlated strongly with each other and with retinal nerve fiber layer (RNFL) thickness, visual fields, and color vision but not with VEPs. For patients with RNFL <75µm, VFQ-25 scores dropped by approximately 2 points for every 1µm decrease in RNFL. CONCLUSION: Among MS patients with visual impairment due to optic neuritis, PR contrast sensitivity could be utilized as a single chart. Visual quality of life was associated with RNFL thinning below 75µm. Copyright Â
BACKGROUND:Visual dysfunction in MS can be quantified using a variety of tests. Many vision tests have not been formally evaluated among MSpatients with existing visual dysfunction. OBJECTIVE: Evaluate several versions of visual acuity and contrast sensitivity tests, measures of central and peripheral vision, retina structure, electrophysiologic function, and quality of life among MSpatients with moderate/severe visual dysfunction. METHODS: Cross-sectional study of 46 patients with stable, incompletely recovered optic neuritis. Testing included Snellen eye charts, several Sloan low contrast charts, Pelli Robson (PR) contrast sensitivity charts, optical coherence tomography, visual fields, Farnsworth Munsell 100-hue test, visual evoked potentials (VEP), and visual function quality of life (VFQ-25) testing. RESULTS: 98% of eyes could read two lines of the PR chart, while only 43% read the 2.5% contrast chart. Low contrast tests correlated strongly with each other and with retinal nerve fiber layer (RNFL) thickness, visual fields, and color vision but not with VEPs. For patients with RNFL <75µm, VFQ-25 scores dropped by approximately 2 points for every 1µm decrease in RNFL. CONCLUSION: Among MSpatients with visual impairment due to optic neuritis, PR contrast sensitivity could be utilized as a single chart. Visual quality of life was associated with RNFL thinning below 75µm. Copyright Â
Authors: L J Balcer; M L Baier; V S Pelak; R J Fox; S Shuwairi; S L Galetta; G R Cutter; M G Maguire Journal: Mult Scler Date: 2000-06 Impact factor: 6.312
Authors: Elena H Martínez-Lapiscina; Santiago Ortiz-Pérez; Elena Fraga-Pumar; Eloy Martínez-Heras; Iñigo Gabilondo; Sara Llufriu; Santiago Bullich; Marc Figueras; Albert Saiz; Bernardo Sánchez-Dalmau; Pablo Villoslada Journal: Mult Scler Date: 2014-01-07 Impact factor: 6.312
Authors: L J Balcer; M L Baier; J A Cohen; M F Kooijmans; A W Sandrock; M L Nano-Schiavi; D C Pfohl; M Mills; J Bowen; C Ford; F R Heidenreich; D A Jacobs; C E Markowitz; W H Stuart; G-S Ying; S L Galetta; M G Maguire; G R Cutter Journal: Neurology Date: 2003-11-25 Impact factor: 9.910
Authors: Christopher G Owen; Alicja R Rudnicka; Liam Smeeth; Jennifer R Evans; Richard P L Wormald; Astrid E Fletcher Journal: BMC Ophthalmol Date: 2006-06-09 Impact factor: 2.209
Authors: Jennifer Graves; Steven L Galetta; Jeffrey Palmer; David H Margolin; Marco Rizzo; John Bilbruck; Laura J Balcer Journal: Mult Scler Date: 2013-03-04 Impact factor: 6.312
Authors: Bernardo Sanchez-Dalmau; Elena H Martinez-Lapiscina; Irene Pulido-Valdeolivas; Irati Zubizarreta; Sara Llufriu; Yolanda Blanco; Nuria Sola-Valls; Maria Sepulveda; Ana Guerrero; Salut Alba; Magi Andorra; Anna Camos; Laura Sanchez-Vela; Veronica Alfonso; Albert Saiz; Pablo Villoslada Journal: PLoS One Date: 2018-04-17 Impact factor: 3.240
Authors: Axel Petzold; Tasanee Braithwaite; Bob W van Oosten; Lisanne Balk; Elena H Martinez-Lapiscina; Russell Wheeler; Nils Wiegerinck; Christiaan Waters; Gordon T Plant Journal: J Neurol Neurosurg Psychiatry Date: 2019-11-18 Impact factor: 10.154